The Prognostic Value of Baseline Clinical and Radiologic Imaging Features in Patients with Unresectable Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab

PURPOSE: To identify prognostic clinical and radiologic features in patients with unresectable hepatocellular carcinoma (HCC) treated with atezolizumab plus bevacizumab. PATIENTS AND METHODS: Clinical and imaging records of patients with unresectable HCC were retrospectively reviewed, and baseline f...

Descripción completa

Detalles Bibliográficos
Autores principales: Awiwi, Muhammad O, Elsayes, Khaled M, Mohamed, Yehia I, Altameemi, Lina, Gjoni, Migena, Irshad, Omayr Muhammad, Sayed Ahmed, Ahmed, Kaseb, Ahmad O, Salem, Usama
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440709/
https://www.ncbi.nlm.nih.gov/pubmed/36065424
http://dx.doi.org/10.2147/JHC.S379428

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440709/
https://www.ncbi.nlm.nih.gov/pubmed/36065424
http://dx.doi.org/10.2147/JHC.S379428

Ejemplares similares